Ubenimex (Compound)

Synonyms:Bestatin, Ubenimex, 58970-76-6, (S)-2-((2S,3R)-3-amino-2-hydroxy-4-phenylbutanamido)-4-methylpentanoic acid, NK-421, (-)-bestatin, Ubenimex (Bestatin), N-[(2S,3R)-3-Amino-2-hydroxy-4-phenylbutyryl]-L-leucine, CHEMBL29292, Bestatin;Ubenimex, N-[(2S,3R)-3-Amino-2-hydroxy-1-oxo-4-phenylbutyl]-L-leucine, 58970-76-6 (free base), (2S)-2-[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanamido]-4-methylpentanoic acid, I0J33N5627, NSC-265489, ((2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl)-L-leucine, L-Leucine, N-[(2S,3R)-3-amino-2-hydroxy-1-oxo-4-phenylbutyl]-, MFCD00083262, 2-(3-AMINO-2-HYDROXY-4-PHENYL-BUTYRYLAMINO)-4-METHYL-PENTANOIC ACID, Ubenimexum [Latin], Ubenimexum, Ubenimex [INN:JAN], SMR000059165, (2S)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]amino]-4-methylpentanoic acid, EINECS 261-529-2, NK 421, NSC 265489, BRN 4704312, Ubestatin, Ubenimex, solid, L-LEUCINE, N-((2S,3R)-3-AMINO-2-HYDROXY-1-OXO-4-PHENYLBUTYL)-, UNII-I0J33N5627, 1txr, Ubenimex- Bio-X, Ubenimex(Bestatin), Ubenimex, Bestatin, Ubenimex,(S), 3-(R)-Amino-2-(S)-hydroxy-4-phenylbutanoyl-(S)-leucine, UBENIMEX [INN], UBENIMEX [JAN], UBENIMEX [MI], UBENIMEX [MART.], UBENIMEX [WHO-DD], SCHEMBL7944, (3-Amino-2-hydroxy-4-phenylbutanoyl)-L-leucine, Lopac0_000214, BSPBio_001553, KBioGR_000273, KBioSS_000273, MLS000028649, MLS001424177, MLS006010137, BCBcMAP01_000178, BDBM23971, KBio2_000273, KBio2_002841, KBio2_005409, KBio3_000545, KBio3_000546, Bio2_000273, Bio2_000753, HMS1361N15, HMS1791N15, HMS1989N15, HMS2052A03, HMS2232H13, HMS3268O06, HMS3402N15, HMS3412N16, HMS3676N16, HMS3715B20, (-)-N-((2S,3R)-3-Amino-2-hydroxy-4-phenylbutyryl)-L-leucine, (S-(R*,S*))-N-(3-Amino-2-hydroxy-4-phenylbutyroyl)-L-leucine, EX-A1292, HY-B0134, BDBM50367209, NSC779839, s1591, AKOS016339610, L-Leucine, N-(3-amino-2-hydroxy-1-oxo-4-phenylbutyl)-, (S-(R*,S*))-, CCG-101071, CS-1910, DB03424, KS-5207, NC00321, NSC-779839, SDCCGSBI-0050202.P003, IDI1_034023, SMP1_000030, NCGC00025323-01, NCGC00025323-02, NCGC00025323-03, NCGC00025323-04, NCGC00025323-05, NCGC00025323-06, NCGC00025323-08, NCGC00025323-14, BU164499, BCP0726000308, U0111, AB00698345_05, EN300-7388593, A832093, SR-01000075724-3, W-105351, [(2S,3R)-3-Amino-2-hydroxy-4-phenylbutanoyl]-Leu, BRD-K59574735-001-02-7, BRD-K59574735-001-05-0, Q10909912, Z2242062173, N-((2S,3R)-3-AMINO-2-HYDROXY-4-PHENYLBUTANOYL)-LEUCINE, N-[(2S,3R)-3-Amino-2-hydroxy-4-phenylbutyryl]-L-leucine, 97%, (2S)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenyl-butanoyl]amino]-4-methyl-pentanoic acid, (S)-2-((2S,3R)-3-amino-2-hydroxy-4-phenylbutanamido)-4-methylpentanoicacid
Pubchem:PUBCHEM:72172
Id:d252bdb4-5c67-5a76-989f-5f63c36d84a0
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Ubenimex's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Ubenimex.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Ubenimex.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.